Ricardo Kratje

Title: The Innovations of Ricardo Kratje

Introduction

Ricardo Kratje, an accomplished inventor from Santa Fe, Argentina, has made significant contributions in the field of biotechnology. His innovative work has led to the development of a notable patent that showcases his expertise and commitment to scientific advancement.

Latest Patents

Kratje holds a patent for a "Modified Human Erythropoietin." This modified version is characterized by an increased plasma half-life and an erythropoietic activity of less than 0.5% compared to native erythropoietin. Remarkably, it maintains the neuroprotective and neuroplastic capacity, achieved through the mutation of at least one of the binding sites of the homodimeric or heterodimeric receptor by incorporating consensus sites for N-glycosylation.

Career Highlights

Throughout his career, Kratje has been associated with notable institutions such as Universidad Nacional del Litoral and Consejo Nacional de Investigaciones Científicas y Técnicas (Conicet). His work in these esteemed organizations has placed him at the forefront of research in biotechnology.

Collaborations

Kratje has collaborated with several prominent researchers, including Marcos Oggero-Eberhardt and María de los Milagros Burgi-Fissolo. Together, they have contributed to advancing knowledge and innovations in their field, making a significant impact on biotechnology and related disciplines.

Conclusion

Ricardo Kratje's journey as an inventor exemplifies dedication to scientific research and innovation. His patent for modified human erythropoietin is a testament to his expertise and serves as an inspiration for future inventors and researchers in the field of biotechnology.